| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0272-6386(97)90456-X |
| P698 | PubMed publication ID | 9186068 |
| P2093 | author name string | Haas M | |
| P2860 | cites work | Ultrastructural changes in IgA nephropathy in relation to histologic and clinical data | Q31013460 |
| A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group | Q34324053 | ||
| Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: survey of the recent literature | Q35442203 | ||
| Low incidence of IgA nephropathy in blacks | Q39865483 | ||
| Increasing incidence of focal-segmental glomerulosclerosis among adult nephropathies: a 20-year renal biopsy study | Q40373809 | ||
| The many masks of focal segmental glomerulosclerosis | Q40597024 | ||
| IgA nephropathy histologically resembling focal-segmental glomerulosclerosis: a clinicopathologic study of 18 cases. | Q51010272 | ||
| Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy. | Q51022307 | ||
| High-dose immunoglobulin therapy for severe IgA nephropathy and Henoch-Schönlein purpura. | Q54032193 | ||
| IgA nephropathy in children: significance of glomerular basement membrane deposition of IgA. | Q64970319 | ||
| Prognostic Indicators in Childhood IgA Nephropathy | Q67750841 | ||
| Double-blind, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritis | Q68034643 | ||
| Proteinuria in IgA nephropathy | Q68351143 | ||
| Development of hypertension in IgA nephropathy as a marker of a poor prognosis | Q68602598 | ||
| IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients | Q68807864 | ||
| IgA nephropathy in Japanese children and adults: a comparative study of clinicopathological features | Q68880208 | ||
| Moderately proteinuric IgA nephropathy: prognostic prediction of individual clinical courses and steroid therapy in progressive cases | Q69759716 | ||
| Alternate-day prednisone therapy in children with IgA-associated nephritis | Q69938288 | ||
| Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses | Q70218307 | ||
| IgA nephropathy: prognostic significance of proteinuria and histological alterations | Q70271554 | ||
| IgA nephropathy: morphologic predictors of progressive renal disease | Q70338385 | ||
| Idiopathic IgA mesangial nephropathy: histological features | Q70394811 | ||
| Crescentic IgA nephropathy | Q70397457 | ||
| Primary IgA nephropathy: prognostic factors | Q70670902 | ||
| A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy. Scientific Planning Committee of the IgA Nephropathy Study | Q71551870 | ||
| IgA nephropathy | Q72171768 | ||
| Racial difference in the prevalence of IgA-associated nephropathies | Q72586777 | ||
| P433 | issue | 6 | |
| P921 | main subject | kidney disease | Q1054718 |
| P304 | page(s) | 829-842 | |
| P577 | publication date | 1997-06-01 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. | |
| P478 | volume | 29 |
| Q61454716 | A case of IgA nephropathy with deep venous thrombosis in the mesentery and lower extremities |
| Q58113293 | A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity |
| Q55237223 | A validation study of crescents in predicting ESRD in patients with IgA nephropathy. |
| Q47422009 | ANCA-positive IgA nephropathy without necrotising or crescentic glomerulonephritis: a clinical conundrum |
| Q41897316 | Aberrant Blood Vessel Formation Connecting the Glomerular Capillary Tuft and the Interstitium Is a Characteristic Feature of Focal Segmental Glomerulosclerosis-like IgA Nephropathy |
| Q62630693 | Accelerated cellular senescence in the kidney: cause or effect of disease progression? |
| Q73323267 | Activation of the acute phase response and complement C3 in patients with IgA nephropathy |
| Q47923312 | Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese pat |
| Q33415013 | Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease |
| Q47839149 | Assessment of the effect of mesangial hypercellularity in childhood nephropathies to the clinical and laboratory findings |
| Q33571848 | Association of C4d deposition with clinical outcomes in IgA nephropathy |
| Q38191664 | Association of megsin 2093C/T, 2180C/T and C25663G gene polymorphism with the risk of IgA nephropathy |
| Q44014239 | C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy |
| Q33416251 | CD(+)(4)CD(+)(25) Treg cells in thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus patients |
| Q53661342 | CD147 renal expression as a biomarker for progressive IgAN. |
| Q38998220 | CD16+CD56+ cells are a potential culprit for hematuria in IgA nephropathy. |
| Q44548657 | CD4 (+)CD 25 (+)Treg cells and IgA nephropathy patients with tonsillectomy: a clinical and pathological study |
| Q36792296 | Canine IgA nephropathy: a case report |
| Q73881245 | Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997 |
| Q37500693 | Chronic kidney disease in an adult with propionic acidemia. |
| Q35008640 | Clinical and histopathological spectrum of IgA nephropathy in Kuwait |
| Q34660643 | Clinical features and outcomes of IgA nephropathy with nephrotic syndrome. |
| Q36465887 | Clinical manifestations of IgA nephropathy combined with thin glomerular basement membrane nephropathy in children |
| Q84805997 | Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy |
| Q45034710 | Comparative study of IgA nephropathy with and without crescents |
| Q51341638 | Comparison of clinicopathological features between children and adults with IgA nephropathy. |
| Q43216357 | Comparison of prominent glomerular injury and prominent tubular injury in immunoglobulin A nephropathy |
| Q37108501 | Continental variations in IgA nephropathy among Asians |
| Q36932203 | Correlates of hematuria on glomerular histology and electron microscopy in IgA nephropathy |
| Q41816657 | Corticosteroids in patients with IgA nephropathy and severe chronic renal damage |
| Q35767449 | CpG array analysis of histone H3 lysine 4 trimethylation by chromatin immunoprecipitation linked to microarrays analysis in peripheral blood mononuclear cells of IgA nephropathy patients |
| Q44478963 | Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide |
| Q37359051 | Development and validation of a prediction rule using the Oxford classification in IgA nephropathy |
| Q47131516 | Development and validation of a prognostic nomogram for IgA nephropathy |
| Q64091471 | Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used? |
| Q50129903 | Diffusion-weighted imaging and pathology of chronic kidney disease: initial study |
| Q34422205 | Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens |
| Q58582390 | Distribution of nephrologists and regional variation in the clinical severity of IgA nephropathy at biopsy diagnosis in Japan: a cross-sectional study |
| Q73453299 | Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy |
| Q46417846 | Effect of Chinese herbs on immunoglobulin A nephropathy: a randomized controlled trial |
| Q37477175 | Effect of IgA aggregates on transforming growth factor-beta1 production in human mesangial cells and the intraglomerular expression of transforming growth factor-beta1 in patients with IgA nephropathy |
| Q50741630 | Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy. |
| Q44444959 | Effect ofIL-6C-572G polymorphism on idiopathic membranous nephropathy risk in a han chinese population |
| Q33807241 | Effects of cyclosporin A therapy combined with steroids and angiotensin converting enzyme inhibitors on childhood IgA nephropathy |
| Q37176853 | Elevated Plasma α-Defensins (HNP1-3) Levels Correlated with IgA1 Glycosylation and Susceptibility to IgA Nephropathy |
| Q34280651 | Expression of P311, a transforming growth factor beta latency-associated protein-binding protein, in human kidneys with IgA nephropathy |
| Q82845446 | Expression of the chemokine receptor CXCR1 in human glomerular diseases |
| Q82900908 | Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. I. Immunohistochemical studies |
| Q43976517 | Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies |
| Q33571375 | Glomerular density in renal biopsy specimens predicts the long-term prognosis of IgA nephropathy |
| Q37612902 | Glomerular diseases in a Hispanic population: review of a regional renal biopsy database |
| Q52892277 | Glomerular epithelial CD44 expression and segmental sclerosis in IgA nephropathy. |
| Q34524136 | Glomerular tip adhesions predict the progression of IgA nephropathy |
| Q33610487 | Glomerulonephritis |
| Q38702034 | HIV-associated immune complex kidney disease |
| Q38484336 | Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: A review. |
| Q35643248 | Haematuria increases progression of advanced proteinuric kidney disease |
| Q36511959 | Haematuria on the Spanish Registry of Glomerulonephritis |
| Q37979775 | Haematuria: the forgotten CKD factor? |
| Q45236430 | High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. |
| Q80249730 | High-dose intravenous immunoglobulin pulse therapy in patients with progressive immunoglobulin A nephropathy: a long-term follow-up |
| Q38148703 | Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification |
| Q45200663 | Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system |
| Q33684014 | Histopathologic features aid in predicting risk for progression of IgA nephropathy |
| Q41145470 | IgA NEPHROPATHY IN PATIENTS RECEIVING A RENAL TRANSPLANT. |
| Q40483788 | IgA Nephropathy in Children: A Multicenter Study in Poland. |
| Q37827152 | IgA nephropathy in India: what we do know |
| Q37157798 | IgA nephropathy in a laboratory worker that progressed to end-stage renal disease: a case report |
| Q38709744 | IgA nephropathy in a tertiary care center from south India |
| Q35468711 | IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells |
| Q38523263 | Immunoglobulin A dominant membranoproliferative glomerulonephritis in an elderly man: A case report and review of the literature |
| Q35649890 | Implication of urinary complement factor H in the progression of immunoglobulin A nephropathy |
| Q73740081 | Insertion/deletion polymorphism in ACE gene is not associated with renal progression in Japanese patients with IgA nephropathy |
| Q46055730 | Interaction between variants of two glycosyltransferase genes in IgA nephropathy |
| Q45833993 | KIM-1 expression predicts renal outcomes in IgA nephropathy. |
| Q49427251 | Life Expectancy for Patients From the Southeastern United States With IgA Nephropathy |
| Q43208703 | Long-term study of mycophenolate mofetil treatment in IgA nephropathy |
| Q37822153 | Nasopharyngeal T-cell monomorphic posttransplant lymphoproliferative disorders and combined IgA nephropathy and membranous glomerulonephritis in a patient with renal transplantation: a case report with literature review |
| Q26786248 | New developments in the genetics, pathogenesis, and therapy of IgA nephropathy |
| Q59313583 | Outcome of IgA nephropathy in adults graded by chronic histological lesions |
| Q44142649 | Overestimation of the risk of progression to end-stage renal disease in the poor prognosis' group according to the 2002 Japanese histological classification for immunoglobulin A nephropathy |
| Q41861363 | Oxford classification of IgA nephropathy: Broadening the scope of the classification |
| Q37455110 | Oxford-MEST classification in IgA nephropathy patients: A report from Iran |
| Q35983485 | Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification |
| Q38008323 | Pathological scenario with the mannose-binding lectin in patients with IgA nephropathy |
| Q38214812 | Pathology of IgA nephropathy |
| Q79888623 | Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels |
| Q35835382 | Percutaneous ultrasound-guided renal biopsy in children: a single centre experience |
| Q35689353 | Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy |
| Q33803944 | Plasmapheresis for crescentic IgA nephropathy: a report of two cases and review of the literature |
| Q79136036 | Poor renal outcome of antineutrophil cytoplasmic antibody negative Pauci-immune glomerulonephritis in Taiwanese |
| Q34726899 | Predicting the risk for dialysis or death in IgA nephropathy |
| Q53150025 | Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). |
| Q38575862 | Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression. |
| Q37621529 | Progression of IgA nephropathy under current therapy regimen in a Chinese population |
| Q35957866 | Proteinuria during Follow-Up Period and Long-Term Renal Survival of Childhood IgA Nephropathy |
| Q38474129 | Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy |
| Q50486052 | Quantitative evaluation of interstitial fibrosis with Sirius Red in IgA nephritis. |
| Q24791691 | Race/ethnicity and disease severity in IgA nephropathy |
| Q40974164 | Rare Variants in the Complement Factor H-Related Protein 5 Gene Contribute to Genetic Susceptibility to IgA Nephropathy |
| Q33863555 | Rationales for treating IgA nephropathies |
| Q53384512 | Real-time histological imaging of kidneys stained with food dyes using multiphoton microscopy. |
| Q42849596 | Recovery of Native Renal Function After Kidney Transplantation |
| Q41638329 | Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy. |
| Q48840358 | Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare |
| Q37135691 | Risk stratification for progression of IgA nephropathy using a decision tree induction algorithm |
| Q40428635 | Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria |
| Q82853644 | Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy |
| Q86392703 | Sequential therapy with cyclophosphamide and mycophenolic acid in patients with progressive immunoglobulin A nephropathy: a long-term follow-up |
| Q92814571 | Serologic and Histologic Predictors of Long-Term Renal Outcome in Biopsy-Confirmed IgA Nephropathy (Haas Classification): An Observational Study |
| Q57764836 | Should a renal biopsy be performed at the first relapse of ‘clinical nephrotic syndrome’? |
| Q45330840 | Significance of the duration of nephropathy for achieving clinical remission in patients with IgA nephropathy treated by tonsillectomy and steroid pulse therapy |
| Q34689564 | Significance of urinary full-length megalin in patients with IgA nephropathy. |
| Q36418707 | Smoking-Related Renal Histologic Injury in IgA Nephropathy Patients. |
| Q35779133 | Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China |
| Q53745800 | The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients. |
| Q33909782 | The Oxford classification as a predictor of prognosis in patients with IgA nephropathy |
| Q34658762 | The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility |
| Q34658768 | The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification |
| Q35750182 | The contribution of B cells to renal interstitial inflammation |
| Q46811070 | The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy |
| Q45435047 | The impact of time-zero biopsy on early graft outcomes after living donor kidney transplantation. |
| Q36237466 | The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression |
| Q46131963 | The level of urinary secretory immunoglobulin A (sIgA) of patients with IgA nephropathy is elevated and associated with pathological phenotypes |
| Q33455868 | The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury |
| Q35142272 | The role of necrotic cell death in the pathogenesis of immune mediated nephropathies. |
| Q34722663 | The safety and short-term efficacy of aliskiren in the treatment of immunoglobulin a nephropathy--a randomized cross-over study |
| Q35985818 | The use of the Oxford classification of IgA nephropathy to predict renal survival |
| Q46510120 | Treatment of IgA nephropathy of adults presented by nephrotic syndrome |
| Q46309050 | Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience |
| Q33179399 | Tubular lesions determine prognosis of IgA nephropathy |
| Q36447934 | Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects |
| Q36874248 | Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases |
| Q35067364 | Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography |
| Q54372616 | Urinary serum- and glucocorticoid-inducible kinase SGK1 reflects renal injury in patients with immunoglobulin A nephropathy. |
| Q49338720 | Utility of Oxford Classification in Post-Transplant Immunoglobulin A Nephropathy |
| Q51250753 | Validation of the Japanese histologic classification 2013 of immunoglobulin A nephropathy for prediction of long-term prognosis in a Japanese single-center cohort. |
| Q84039211 | Validation of the Oxford classification of IgA nephropathy |
| Q34488531 | Validation of the Oxford classification of IgA nephropathy for pediatric patients from China. |
| Q36237957 | Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults |
| Q97418576 | Validation of the revised Oxford classification for IgA nephropathy considering treatment with corticosteroids/immunosuppressors |
| Q35664626 | Validation study of oxford classification of IgA nephropathy: the significance of extracapillary proliferation |
| Q38860793 | Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy? |
| Q52546301 | [Berger's disease in childhood] |
Search more.